Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESERVE: LUPKYNIS in Combination Therapy for Lupus Nephritis
NCT07611214Phase 4Recruiting
- Sponsor
- Aurinia
- Start
- Apr 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 4 trial of voclosporin in lupus nephritis (LN), sponsored by Aurinia. Started Apr 2026; status: recruiting.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT07611214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07611214.